aTyr Pharma Inc (LIFE) Insider Trading
- $11,508,082.40
- $7,644,609.27
- May 31, 2024
- Paul Schimmel
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 31, 2024 | CEO | 20,000 | $1.81 | Buy | $36,200.00 | |
May 31, 2024 | CFO | 5,000 | $1.79 | Buy | $8,950.00 | |
May 30, 2024 | Director | 50,000 | $1.75 | Buy | $87,500.00 | |
Dec. 11, 2023 | CEO | 3,000 | $1.17 | Buy | $3,510.00 | |
May 10, 2023 | Director | 200,000 | $2.25 | Buy | $450,000.00 | |
Feb. 6, 2023 | CFO | 1,566 | $2.36 | Sell | $3,695.76 | |
Nov. 21, 2022 | CEO | 10,000 | $2.14 | Buy | $21,400.00 | |
July 1, 2022 | CEO | 15,000 | $2.88 | Buy | $43,200.00 | |
Jan. 13, 2022 | CFO | 1,923 | $6.75 | Buy | $12,980.25 | |
Nov. 15, 2021 | CEO | 2,500 | $8.57 | Buy | $21,425.00 | |
Sept. 20, 2021 | Director | 250,000 | $8.00 | Buy | $2,000,000.00 | |
May 21, 2021 | Director | 2,500 | $4.34 | Sell | $10,850.00 | |
May 18, 2021 | Director | 50,000 | $3.98 | Buy | $199,000.00 | |
May 18, 2021 | CEO | 10,000 | $4.01 | Buy | $40,100.00 | |
Feb. 9, 2021 | CFO | 390 | $7.66 | Sell | $2,987.40 | |
Feb. 9, 2021 | CEO | 778 | $7.66 | Sell | $5,959.48 | |
Sept. 2, 2020 | Director | 7,260 | $4.01 | Sell | $29,112.60 | |
Aug. 28, 2020 | Director | 100 | $4.00 | Sell | $400.00 | |
Aug. 26, 2020 | Director | 2,200 | $4.30 | Sell | $9,460.00 | |
June 19, 2020 | CFO | 1,850 | $4.22 | Buy | $7,807.00 | |
June 19, 2020 | CEO | 6,000 | $4.27 | Buy | $25,620.00 | |
Feb. 10, 2020 | Director | 254,000 | $4.00 | Buy | $1,016,000.00 | |
May 17, 2019 | General Counsel | 4,651 | $0.45 | Sell | $2,092.95 | |
Dec. 21, 2018 | Director | 245,000 | $0.42 | Buy | $102,900.00 | |
Nov. 26, 2018 | Director | 147,225 | $0.54 | Buy | $79,501.50 | |
Sept. 20, 2018 | CFO | 64,000 | $0.83 | Buy | $53,120.00 | |
Sept. 14, 2018 | CFO | 26,000 | $0.73 | Buy | $18,980.00 | |
Sept. 4, 2018 | Director | 42,749 | $0.74 | Buy | $31,634.26 | |
Aug. 30, 2018 | Director | 164,411 | $0.74 | Buy | $121,664.14 | |
May 18, 2018 | Director | 150,000 | $1.00 | Buy | $150,000.00 | |
May 16, 2018 | Major Shareholder | 3,209,316 | $0.93 | Sell | $2,984,663.88 | |
Feb. 8, 2018 | Insider | 1,402 | $3.40 | Sell | $4,766.80 | |
Aug. 31, 2017 | Director | 94,336 | $2.65 | Buy | $249,990.40 | |
Aug. 31, 2017 | CEO | 37,736 | $2.65 | Buy | $100,000.40 | |
April 24, 2017 | CEO | 124 | $3.00 | Buy | $372.00 | |
April 20, 2017 | CEO | 2,552 | $3.00 | Buy | $7,656.00 | |
Dec. 21, 2016 | Director | 25,000 | $2.28 | Buy | $57,000.00 | |
Dec. 20, 2016 | VP | 11,000 | $2.25 | Buy | $24,750.00 | |
Dec. 19, 2016 | CEO | 69,000 | $2.20 | Buy | $151,800.00 | |
Dec. 16, 2016 | Director | 50,000 | $2.48 | Buy | $124,000.00 | |
May 11, 2016 | Insider | 12,412 | $3.04 | Buy | $37,732.48 | |
April 14, 2016 | Director | 66,219 | $4.18 | Buy | $276,795.42 | |
April 13, 2016 | Director | 9,835 | $3.85 | Buy | $37,864.75 | |
April 12, 2016 | Director | 9,127 | $3.71 | Buy | $33,861.17 | |
April 11, 2016 | Director | 32,659 | $3.57 | Buy | $116,592.63 | |
April 8, 2016 | Director | 85,000 | $3.22 | Buy | $273,700.00 | |
April 7, 2016 | Director | 40,000 | $3.19 | Buy | $127,600.00 | |
April 6, 2016 | Director | 25,000 | $3.20 | Buy | $80,000.00 | |
April 5, 2016 | CEO | 2,500 | $3.55 | Buy | $8,875.00 | |
April 5, 2016 | Director | 25,000 | $3.52 | Buy | $88,000.00 |
Insiders are both buying and selling aTyr Pharma Inc stock.
The insider traders at aTyr Pharma Inc are: Paul Schimmel, Sanjay Shukla, Jill Marie Broadfoot, John Mendlein, John K Clarke, Ashraf Amanullah, John A Cottingham, James E Flynn, Grove Matsuoka, Nancy Krueger, Ecor1 Capital Fund Qualified,, David C Uprichard, Sofinnova Venture Partners Ix,, and Timothy Coughlin
The most active insider trader at aTyr Pharma Inc is Paul Schimmel with 19 trades.
John A Cottingham has sold the most aTyr Pharma Inc stock with a total value of $8,883,600.00.
Sofinnova Venture Partners Ix, has bought the most aTyr Pharma Inc stock with a total value of $8,960,000.00.
The most recent insider trade for aTyr Pharma Inc was on May 31, 2024.
The single biggest insider buy for aTyr Pharma Inc was from Sofinnova Venture Partners Ix, with a total value of $4,480,000.00 on May 12, 2015.
The single biggest insider sell for aTyr Pharma Inc was from John A Cottingham with a total value of $4,441,800.00 on May 28, 2013.